Lung adenocarcinoma is the most common type of lung cancer, accounting for the majority of cancer-related fatalities in the US. There are various causes of lung adenocarcinoma, one of which is a mutation in a protein known as EGFR. Non-mutant EGFR stimulates cell proliferation in response to
Researchers at Mount Sinai's Icahn School of Medicine have discovered an allergy route that, when inhibited, activates antitumor immunity in animal models of non-small cell lung cancer (NSCLC).
Researchers discovered that immune cells actively and closely guide the formation of human lung tissue throughout development, revolutionising our understanding of early lung development and the role of immune cells beyond immunity.
According to the information given by AIIMS, "Department of Pulmonary, Critical Care and Sleep Medicine, AIIMS, New Delhi is conducting a pilot study to see the effect of Low dose CT on early lung cancer diagnosis."
Researchers discovered that immune cells play an active and intimate role in guiding the growth of human lung tissue throughout development, revolutionising our understanding of early lung development and the role of immune cells beyond immunity
Lung cancer affects more individuals each year than any other malignancy. Nonetheless, a new study led by Curtin University revealed that people with incurable forms of the condition may survive longer if they engage in less than five minutes of physical activity per day.
More people die from lung cancer annually worldwide than from any other cancer. Nevertheless, a recent study headed by Curtin University discovered that individuals with incurable forms of the disease may live longer if they engage in less than five minutes of physical activity each day.
According to a study conducted by the University of Adelaide and Oxford University, asbestos exposure caused a higher prevalence of asbestos-related lung malignancies among British and Australian navy personnel than in other armed forces.
New research led by NYU Langone Health and its Perlmutter Cancer Centre suggested that rather than analyzing the tumours themselves, genetic data from seemingly healthy tissue close to lung tumours may be a better indicator of whether cancer will recur after treatment.
A comprehensive international study that was published in Radiology found that employing low-dose computed tomography (CT) screening to identify early-stage lung cancer greatly increases the disease's cure rate over a 20-year span.
According to new research headed by NYU Langone Health and its Perlmutter Cancer Centre, genetic information taken from seemingly healthy tissue near lung tumours may be a better predictor of whether cancer will return following therapy than analysis of the tumours themselves.
According to a large-scale multinational study published in Radiology, detecting early-stage lung cancer using low-dose computed tomography (CT) screening significantly enhances its cure rate over a 20-year period.